Vascular Parkinsonism: Clinical Trials

1 trial for Vascular Parkinsonism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Vascular Parkinsonism: new trials by email Literature Review of Vascular Parkinsonism trials Research Report on Vascular Parkinsonism

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Parkinson's And Zoledronic Acid
Zoledronic Acid 5Mg/Bag 100Ml Inj, Placebo - Parkinson Disease, Osteoporosis
Phase 4CompletedCalifornia Pacific Medical Center Research Institute27212019-11-152026-06-25

Narrower conditions

Fractures, Bone (1)  ·  Lewy Body Disease (1)  ·  Multiple System Atrophy (1)  ·  Osteoporosis (1)  ·  Parkinson Disease (1)  ·  Parkinsonian Disorders (1)  ·  Supranuclear Palsy, Progressive (1)

Broader conditions

Autonomic Nervous System Diseases (1)  ·  Basal Ganglia Diseases (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cranial Nerve Diseases (1)  ·  Dementia (1)  ·  Eye Diseases (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)  ·  Movement Disorders (1)  ·  Musculoskeletal Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)

Interventions

Zoledronic Acid (1)

Sponsors

California Pacific Medical Center Research Institute (1)

Countries

United States (1)

Top investigators

Steve Cummings, MD (1)

Results publications

PMID 33649343

NIH funding

R01AG059417 (1)